Tumor size is associated with adjuvant chemotherapy benefit in T1N0M0 triple-negative breast cancer: a multicenter and propensity score matched analysis

BACKGROUND: Triple-negative breast cancer (TNBC) is characterized by aggressive phonotypes and relatively poor outcomes. There are controversies on the effect of adjuvant chemotherapy in small (T1N0M0) TNBCs, especially among T1a-b patients. This study evaluated the survival benefit of adjuvant chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chenghui, Huang, Ou, Wu, Jiayi, Shen, Kunwei, Chen, Xiaosong, Zhu, Siji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660177/
https://www.ncbi.nlm.nih.gov/pubmed/38021197
http://dx.doi.org/10.21037/gs-23-189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660177/
https://www.ncbi.nlm.nih.gov/pubmed/38021197
http://dx.doi.org/10.21037/gs-23-189

Ejemplares similares